Literature DB >> 23609993

Motor functioning during and following treatment with chemotherapy for pediatric acute lymphoblastic leukemia.

Jessica L Green1, Sarah J Knight, Maria McCarthy, Cinzia R De Luca.   

Abstract

This systematic review evaluated empirical studies examining motor skills in children during and following treatment for acute lymphoblastic leukemia. Most studies indicated that children on-treatment display poorer gross and fine motor abilities than healthy peers, but generally have intact visual-motor integration skills. Studies have reported gross motor difficulties in 5-54% of survivors. There is some limited evidence for long-term fine motor deficits. The evidence for visual-motor integration difficulties in the survivor population is less consistent. Larger studies with a longitudinal design are needed to further specify the onset and timing of motor difficulties and ascertain risk factors.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23609993     DOI: 10.1002/pbc.24537

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  Associating Physical Activity Levels with Motor Performance and Physical Function in Childhood Survivors of Acute Lymphoblastic Leukemia.

Authors:  Stanley H Hung; Anne Rankin; Naznin Virji-Babul; Sheila Pritchard; Christopher Fryer; Kristin L Campbell
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

Review 2.  Peripheral neuropathy in children and adolescents treated for cancer.

Authors:  Kari L Bjornard; Laura S Gilchrist; Hiroto Inaba; Barthelemy Diouf; Marilyn J Hockenberry; Nina S Kadan-Lottick; Daniel C Bowers; M Eileen Dolan; Nicole J Ullrich; William E Evans; Kirsten K Ness
Journal:  Lancet Child Adolesc Health       Date:  2018-09-01

Review 3.  Early Traumatic Stress Responses in Parents Following a Serious Illness in Their Child: A Systematic Review.

Authors:  Claudia Woolf; Frank Muscara; Vicki A Anderson; Maria C McCarthy
Journal:  J Clin Psychol Med Settings       Date:  2016-03

Review 4.  Developmental origins and emerging therapeutic opportunities for childhood cancer.

Authors:  Mariella Filbin; Michelle Monje
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

5.  Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.

Authors:  Erin M Gibson; Surya Nagaraja; Alfonso Ocampo; Lydia T Tam; Lauren S Wood; Praveen N Pallegar; Jacob J Greene; Anna C Geraghty; Andrea K Goldstein; Lijun Ni; Pamelyn J Woo; Ben A Barres; Shane Liddelow; Hannes Vogel; Michelle Monje
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

6.  Motor performance in children and adolescents with cancer at the end of acute treatment phase.

Authors:  Miriam Götte; Sabine V Kesting; Corinna C Winter; Dieter Rosenbaum; Joachim Boos
Journal:  Eur J Pediatr       Date:  2014-11-28       Impact factor: 3.183

7.  Skeletal Muscle and Childhood Cancer: Where are we now and where we go from here.

Authors:  Chelsea G Goodenough; Robyn E Partin; Kirsten K Ness
Journal:  Aging Cancer       Date:  2021-05-20

Review 8.  Extracellular Vesicles and Cancer Therapy: Insights into the Role of Oxidative Stress.

Authors:  Jenni Ho; Luksana Chaiswing; Daret K St Clair
Journal:  Antioxidants (Basel)       Date:  2022-06-17

9.  Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic Leukemia.

Authors:  Marilyn J Hockenberry; Kevin R Krull; Kathleen C Insel; Lynnette L Harris; Patricia M Gundy; Kristin B Adkins; Alice E Pasvogel; Olga A Taylor; Kari M Koerner; David W Montgomery; Adam K Ross; Adam Hill; Ida M Moore
Journal:  Oncol Nurs Forum       Date:  2015-09       Impact factor: 2.172

10.  Physical Activity Participation and Preferences: Developmental and Oncology-Related Transitions in Adolescents Treated for Cancer.

Authors:  Marilyn Wright
Journal:  Physiother Can       Date:  2015-08       Impact factor: 1.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.